Medicare Enrolled

Dr. Sohail Ali, M.D.

Endocrinology · Maitland, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
635 N MAITLAND AVE, Maitland, FL 32751
4076294901
In practice since 2005 (20 years)
NPI: 1235137167 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Sohail Ali is an endocrinology in Maitland, FL, with 20 years in practice. Based on federal Medicare data, Dr. Ali performed 12,667 Medicare services across 7,333 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ali received a total of $13,021 from 53 pharmaceutical and/or device companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 6% volume in FL$ $13,021 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,667
Medicare services
Top 6% in FL for endocrinology
7,333
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~633 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,308$90$190
Blood draw (venipuncture)1,193$8$19
Comprehensive metabolic blood panel1,083$10$35
Hemoglobin A1c test (diabetes monitoring)759$10$40
Thyroid stimulating hormone (TSH) test723$16$55
Thyroxine (thyroid chemical), total718$7$22
Thyroid hormone evaluation718$6$25
Creatinine test (kidney function)679$5$40
Lipid panel (cholesterol and triglycerides)649$13$61
Ldl cholesterol level647$10$21
Complete blood count (CBC) with differential647$8$22
Urine microalbumin (protein) analysis454$6$26
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report378$26$65
Parathyroid hormone level test330$40$165
Collagen cross links test, (urine test to evaluate bone health)228$18$90
Vitamin D level test220$29$125
Office visit, established patient (20-29 min)214$61$170
Ultrasound scan of head and neck soft tissue195$73$250
Bone density scan (DEXA)190$36$225
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment163$98$300
Diabetes outpatient self-management training services, individual, per 30 minutes102$40$75
Creatine kinase (cardiac enzyme) level, total92$6$35
New patient office visit (45-59 min)80$117$300
Remote patient monitoring management, 20 min/month80$37$55
Thyroglobulin (thyroid protein) antibody measurement75$16$50
Urine volume measurement58$4$5
Injection, zoledronic acid, 1 mg55$6$225
Office visit, established patient, complex (40-54 min)54$131$225
Thyroid hormone, t3 measurement, free51$17$95
Thyroglobulin (thyroid related hormone) level49$16$105
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional44$16$50
Cortisol (hormone) measurement, total43$16$75
Sex hormone binding globulin (protein) level41$21$85
Testosterone (hormone) level, total41$25$130
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes38$11$20
Urine calcium level34$6$26
Microsomal antibodies (autoantibody) measurement31$14$50
Vitamin B-12 level test29$15$25
Magnesium level test25$7$26
Total protein level, urine24$4$30
Fine needle aspiration biopsy using ultrasound guidance, first growth23$100$600
Chronic care management, first 20 min/month21$49$64
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)21$47$64
C-peptide (protein) level19$20$35
Prolactin (milk producing hormone) level15$19$74
New patient office visit, complex (60-74 min)15$157$325
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less11$49$80
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
2.2% medium
97.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,021
Total received (2018-2024)
Avg $1,860/year across 7 years
Top 25% in FL for endocrinology
53
Companies
456
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,474 (65.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,547 (34.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,509
2023
$1,435
2022
$182
2021
$193
2020
$3,573
2019
$2,904
2018
$3,226

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tandem Diabetes Care, Inc.
$4,894
Novo Nordisk Inc
$977
Lilly USA, LLC
$851
SANOFI-AVENTIS U.S. LLC
$608
Radius Health, Inc.
$520
Dexcom, Inc.
$500
Amgen Inc.
$371
AstraZeneca Pharmaceuticals LP
$325
Boehringer Ingelheim Pharmaceuticals, Inc.
$300
IBSA Pharma Inc.
$288
Merck Sharp & Dohme Corporation
$261
Janssen Pharmaceuticals, Inc
$212
Amneal Pharmaceuticals LLC
$203
AbbVie, Inc.
$185
Abbott Laboratories
$184
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$173
Bayer Healthcare Pharmaceuticals Inc.
$170
Medtronic MiniMed, Inc.
$163
Senseonics, Incorporated
$138
PFIZER INC.
$135
Amarin Pharma Inc.
$118
Ipsen Biopharmaceuticals, Inc
$116
AbbVie Inc.
$97
Insulet Corporation
$95
Shire North American Group Inc
$94
CeQur Corporation
$77
ABBVIE INC.
$76
Antares Pharma, Inc.
$71
Kyowa Kirin, Inc.
$68
Kowa Pharmaceuticals America, Inc.
$61
RECORDATI_RARE_DISEASES_INC.
$60
Gemini Laboratories, LLC
$57
Valeritas, Inc.
$56
BETA BIONICS, INC.
$52
Corcept Therapeutics
$51
Averitas Pharma Inc.
$41
Xeris Pharmaceuticals, Inc.
$38
Endo Pharmaceuticals Inc.
$34
Horizon Therapeutics plc
$34
Rhythm Pharmaceuticals, Inc.
$33
Neurocrine Biosciences, Inc.
$26
Astellas Pharma US Inc
$21
Amphastar Pharmaceuticals, Inc.
$20
Ascensia Diabetes Care Us Inc.
$19
Roche Diabetes Care, Inc.
$19
Supernus Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
LIFESCAN, INC.
$16
Renalytix AI, Inc.
$16
Medtronic, Inc.
$16
Strongbridge US INC.
$15
Ferring Pharmaceuticals Inc.
$14
MannKind Corporation
$13
Top 3 companies account for 51.6% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · BASAGLAR · CYCLOSET · Cables · CeQur Simplicity · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DISEASE STATE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · Eversense · FARXIGA · FORTEO · FreeStyle Libre Pro · FreeStyle Lite system · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · INVOKANA · Increlex · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Kits and Accessories · Korlym · LICART · Livalo · MACRILEN · MINIMED 780G · MOUNJARO · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · Norditropin · ONETOUCH VERIO FLEX · Omnipod · Otrexup · Ozempic · PREVNAR 20 · Prolia · QUTENZA · RECORLEV · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SYNJARDY · SYNTHROID · Saxenda · Software · Sogroya · Somatuline Depot · Synthroid · TEPEZZA · TESTOPEL · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $103 per 100 Medicare services performed
Looking for a endocrinology in Maitland?
Compare endocrinologys in the Maitland area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
59
Per 100K population
4.1
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
5.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ali is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ali performed 1,308 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $13,021 from 53 companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other endocrinologys in Maitland?
Dr. Ali's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →